Bronchiectases at Early Chest Computed Tomography in Children with Cystic Fibrosis Are Associated with Increased Risk of Subsequent Pulmonary Exacerbations and Chronic Pseudomonas Infection
Overview
Authors
Affiliations
Background: Children with cystic fibrosis (CF) are often Pseudomonas aeruginosa (PsA) free and exhibit normal spirometry between the ages of 5 and 7. It is reported that computed tomography (CT) is more sensitive than FEV1 as an instrument in the identification of pulmonary disease. It is not known whether CF-CT scores in childhood may be used to highlight children at risk of developing severe disease.
Aims: 1 - To assess the number of respiratory exacerbations (RTEs) during a follow-up period of 6 years and their correlation with the CF-CT scores in young CF children. 2 - To assess whether PsA-negative CF children with high chest CF-CT scores are more likely to develop chronic PsA lung infection.
Methods: 68 chest CT performed in patients without chronic PsA infection were scored. All patients (median age 7.8 years) had at least 4 clinical, functional and microbiologic assessments/year in the subsequent 6 years. RTE was defined as hospitalization and IV antibiotic treatment for respiratory symptoms.
Results: 86.8% patients had <3 RTEs in the 6 year follow-up period. The number of RTEs in the 6 years subsequent to the CT scan was correlated to the bronchiectasis CT score (BCTS) (r = 0.612; p < 0.001) and to FEV1 at baseline (r = -0.495, p<0.001). A BCTS ≥ 17.5 identified patients with >3 RTEs during follow-up (sensitivity: 100%, specificity: 85%), while FEV1 did not. Only BCTS was significant in a logistic multivariate model (RR 1.15). BCTS was significantly lower and FEV1 higher in patients who did not develop chronic PsA infection by the end of the study.
Conclusion: In CF children free from chronic PsA, both CT scores and FEV1 values demonstrate significant correlation with disease severity in the subsequent 6 years but CT score has higher predictive value in the identification of patients at risk.
Kim S, Shapiro J, Cottrill K, Collins G, Shanthikumar S, Rao P Free Radic Biol Med. 2023; 206:180-190.
PMID: 37356776 PMC: 10513041. DOI: 10.1016/j.freeradbiomed.2023.06.021.
Ciet P, Bertolo S, Ros M, Casciaro R, Cipolli M, Colagrande S Eur Respir Rev. 2022; 31(163).
PMID: 35321929 PMC: 9489084. DOI: 10.1183/16000617.0173-2021.
Meltzer C, Gilljam M, Vikgren J, Norrlund R, Vult von Steyern K, Bath M Radiat Prot Dosimetry. 2021; 195(3-4):434-442.
PMID: 33683309 PMC: 8507459. DOI: 10.1093/rpd/ncab017.
Airway tapering: an objective image biomarker for bronchiectasis.
Kuo W, Perez-Rovira A, Tiddens H, De Bruijne M Eur Radiol. 2020; 30(5):2703-2711.
PMID: 32025831 PMC: 7160094. DOI: 10.1007/s00330-019-06606-w.
Bouma N, Janssens H, Andrinopoulou E, Tiddens H Pediatr Pulmonol. 2019; 55(1):141-148.
PMID: 31496137 PMC: 6972540. DOI: 10.1002/ppul.24498.